Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial

Dermatology : International Journal for Clinical and Investigative Dermatology
K ReichChristopher E M Griffiths

Abstract

The EXPRESS study demonstrated the initial efficacy of infliximab in psoriasis affecting the skin and nails. To further assess how patients with a positive initial response to infliximab respond to 1 year of continuous infliximab treatment. A retrospective analysis of patients with moderate-to-severe plaque and nail psoriasis who initiated and continued infliximab treatment up to week 46 was conducted. Among all nail psoriasis patients receiving 1 year of infliximab (n = 186), 74.6 and 54.1% achieved at least 75 or 90% improvement in the Psoriasis Area and Severity Index (PASI) at week 50. These PASI-75 (n = 138) and PASI-90 (n = 100) responders had respective mean improvements from baseline to week 50 of 93.6 and 97.3% for the PASI, 90.6 and 94.1% for the Dermatology Life Quality Index (DLQI) and 78.2 and 80.3% for the Nail Psoriasis Severity Index (NAPSI). Infliximab treatment for 1 year produced sustained improvement in PASI, DLQI and NAPSI scores.

Citations

Sep 6, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marina PapoutsakiAntonio Costanzo
Jul 13, 2012·American Journal of Clinical Dermatology·Eugene S T TanHong Liang Tey
Jun 14, 2013·Dermatology Research and Practice·Yasemin Oram, A Deniz Akkaya
May 24, 2014·Actas dermo-sifiliográficas·M Sánchez-RegañaUNKNOWN en representación del Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología
Jul 30, 2011·The Journal of Dermatological Treatment·Aikaterini PatsatsiDimitrios Sotiriadis
Dec 6, 2011·The Journal of Dermatological Treatment·Aikaterini KyriakouDimitrios Sotiriadis
Oct 26, 2013·Expert Opinion on Biological Therapy·Aikaterini KyriakouDimitrios Sotiriadis
Jun 28, 2011·Annales de dermatologie et de vénéréologie·Serge Boulinguez, Sébastien Barbarot
Oct 15, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Federico BardazziAnnalisa Patrizi
Oct 15, 2013·The British Journal of Dermatology·P RichUNKNOWN PHOENIX 1 investigators
Dec 3, 2014·La Presse médicale·Robert Baran
Apr 5, 2016·Drugs·Marcel C Pasch
Feb 20, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·R G LangleyM P Heffernan
May 25, 2016·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A Schmieder, W K Peitsch
Jan 19, 2017·Anais Brasileiros De Dermatologia·Gleison Vieira DuarteEdgar Marcelino de Carvalho
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Anna Christa Q de VriesPhyllis I Spuls
Mar 1, 2018·American Journal of Clinical Dermatology·Danielle R McClanahan, Joseph C English
Jan 29, 2016·Medwave·Andrea Antúnez-LayRomina Andino-Navarrete
Nov 5, 2014·The Journal of Rheumatology·April W ArmstrongArthur Kavanaugh
Jul 16, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·B E ElewskiP A Rich
Jan 10, 2020·The Cochrane Database of Systematic Reviews·Emilie SbidianLaurence Le Cleach
Apr 7, 2020·The Journal of Dermatological Treatment·Boni ElewskiAbby Jacobson
Dec 23, 2017·The Cochrane Database of Systematic Reviews·Emilie SbidianLaurence Le Cleach
Mar 23, 2021·Dermatologic Clinics·Dimitrios RigopoulosStamatios Gregoriou
Apr 20, 2021·The Cochrane Database of Systematic Reviews·Emilie SbidianLaurence Le Cleach

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.